Blanket hepatitis B vaccination is questionable in IndiaBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7547.976 (Published 20 April 2006) Cite this as: BMJ 2006;332:976
- Peter R Mansfield, director (email@example.com),
- Anant Phadke,
- Ashok Kale
- Healthy Skepticism, Willunga, SA 5041, Australia
EDITOR—We agree with Banatvala et al that adequate economic analysis of universal hepatitis B vaccination is required before recommending policy change in Britain.1 In India plans for universal hepatitis B vaccination have been announced without an economic comparison with other programmes that may be more cost effective.
The marginal cost-efficacy of hepatitis B vaccine in India has been estimated, …